| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Big Techs and startups in pharmaceutical R&D – A 2020 perspective on artificial intelligence
|
Schuhmacher, Alexander
|
|
|
26 |
10 |
p. 2226-2231
|
artikel
|
| 2 |
Contents page 1
|
|
|
|
26 |
10 |
p. i
|
artikel
|
| 3 |
Contents page 2
|
|
|
|
26 |
10 |
p. ii
|
artikel
|
| 4 |
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
|
Weidolf, Lars
|
|
|
26 |
10 |
p. 2244-2258
|
artikel
|
| 5 |
Drug combination therapy for emerging viral diseases
|
Shyr, Zeenat A.
|
|
|
26 |
10 |
p. 2367-2376
|
artikel
|
| 6 |
Epigenetics and therapeutic targets in gastrointestinal malignancies
|
Nagaraju, Ganji Purnachandra
|
|
|
26 |
10 |
p. 2303-2314
|
artikel
|
| 7 |
European countries in the race to attract successful biopharma investment: Winners and laggers
|
March-Chordà, Isidre
|
|
|
26 |
10 |
p. 2209-2213
|
artikel
|
| 8 |
Frontiers in PROTACs
|
Hughes, Gregory R.
|
|
|
26 |
10 |
p. 2377-2383
|
artikel
|
| 9 |
High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
|
Xu, Tuan
|
|
|
26 |
10 |
p. 2439-2444
|
artikel
|
| 10 |
Histone lysine methyltransferase SET8 is a novel therapeutic target for cancer treatment
|
Yang, Chao
|
|
|
26 |
10 |
p. 2423-2430
|
artikel
|
| 11 |
Identification of biological targets through the correlation between cell line chemosensitivity and protein expression pattern
|
Lauria, Antonino
|
|
|
26 |
10 |
p. 2431-2438
|
artikel
|
| 12 |
IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseases
|
De Ceuninck, Frédéric
|
|
|
26 |
10 |
p. 2465-2473
|
artikel
|
| 13 |
Immunotherapy to get on point with base editing
|
Harbottle, Jennifer A.
|
|
|
26 |
10 |
p. 2350-2357
|
artikel
|
| 14 |
Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and value
|
Prigodich, Andrew E.
|
|
|
26 |
10 |
p. 2232-2237
|
artikel
|
| 15 |
Integrated nanomaterials for non-invasive photothermal therapy of rheumatoid arthritis
|
Gadeval, Anuradha
|
|
|
26 |
10 |
p. 2315-2328
|
artikel
|
| 16 |
Leucine as an excipient in spray dried powder for inhalation
|
Alhajj, Nasser
|
|
|
26 |
10 |
p. 2384-2396
|
artikel
|
| 17 |
Mechanisms of thrombosis and research progress on targeted antithrombotic drugs
|
Zhang, Lei
|
|
|
26 |
10 |
p. 2282-2302
|
artikel
|
| 18 |
Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery
|
Parmar, Prashantkumar K.
|
|
|
26 |
10 |
p. 2329-2349
|
artikel
|
| 19 |
Regulatory density as a means to refine current regulatory approaches for increasingly complex medicines
|
Klein, Kevin
|
|
|
26 |
10 |
p. 2221-2225
|
artikel
|
| 20 |
Robust preclinical evidence in somatic cell genome editing: A key driver of responsible and efficient therapeutic innovations
|
Bittlinger, Merlin
|
|
|
26 |
10 |
p. 2238-2243
|
artikel
|
| 21 |
Small molecules targeting ubiquitination to control inflammatory diseases
|
Li, Zheng-Qing
|
|
|
26 |
10 |
p. 2414-2422
|
artikel
|
| 22 |
Specificity of pharmacokinetic modeling of nanomedicines
|
Lebreton, Vincent
|
|
|
26 |
10 |
p. 2259-2268
|
artikel
|
| 23 |
Stimuli-responsive hydrogels for intratumoral drug delivery
|
Marques, Ana C.
|
|
|
26 |
10 |
p. 2397-2405
|
artikel
|
| 24 |
Structural insights into understudied human cytochrome P450 enzymes
|
Machalz, David
|
|
|
26 |
10 |
p. 2456-2464
|
artikel
|
| 25 |
TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery
|
Xiang, Shuang
|
|
|
26 |
10 |
p. 2445-2455
|
artikel
|
| 26 |
The European Lead Factory: An updated HTS compound library for innovative drug discovery
|
van Vlijmen, Herman
|
|
|
26 |
10 |
p. 2406-2413
|
artikel
|
| 27 |
The fight against COVID-19: Striking a balance in the renin–angiotensin system
|
Dean, Alexis Q.
|
|
|
26 |
10 |
p. 2214-2220
|
artikel
|
| 28 |
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
|
Qiu, Tingting
|
|
|
26 |
10 |
p. 2269-2281
|
artikel
|
| 29 |
The promise of crowdfunding to finance R&D of novel diagnostics and therapeutics for incurable diseases
|
Tóth, Gergely
|
|
|
26 |
10 |
p. 2205-2208
|
artikel
|
| 30 |
Validation strategies for identifying drug targets in dermal fibrotic disorders
|
Norouzi-Barough, Leyla
|
|
|
26 |
10 |
p. 2474-2485
|
artikel
|
| 31 |
Web resources facilitate drug discovery in treatment of COVID-19
|
Mei, Long-Can
|
|
|
26 |
10 |
p. 2358-2366
|
artikel
|
Tijdschrift beschrijving